Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous bronchial basal cells for COPD
NCT03655795Phase 1Unknown
- Sponsor
- Ruijin Hospital
- Start
- Nov 2018
- Primary completion
- Sep 2020
01
Overview
Phase 1, open-label trial in chronic obstructive pulmonary disease (COPD), sponsored by Ruijin Hospital. Primary endpoint: Diffusing capacity of the lung for carbon monoxide at 1 year. Status: unknown.
02
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT03655795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03655795.